TTK Capital Surpluse from 2010 to 2024

TTKHLTCARE   1,458  12.90  0.88%   
TTK Healthcare's Capital Surpluse is decreasing over the years with slightly volatile fluctuation. Capital Surpluse is expected to dwindle to about 78.6 M. During the period from 2010 to 2024 TTK Healthcare Capital Surpluse annual values regression line had geometric mean of  96,120,710 and mean square error of 22.1 T. View All Fundamentals
 
Capital Surpluse  
First Reported
2010-12-31
Previous Quarter
88.4 M
Current Value
78.6 M
Quarterly Volatility
5.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check TTK Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TTK Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 79.7 M, Interest Expense of 24.1 M or Total Revenue of 4.8 B, as well as many indicators such as . TTK financial statements analysis is a perfect complement when working with TTK Healthcare Valuation or Volatility modules.
  
This module can also supplement various TTK Healthcare Technical models . Check out the analysis of TTK Healthcare Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in TTK Stock

TTK Healthcare financial ratios help investors to determine whether TTK Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in TTK with respect to the benefits of owning TTK Healthcare security.